RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: myocardial infarction
Accession: DOID:5844
browse the term
Definition: A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia. (DO)
Synonyms: exact_synonym: Cardiovascular Stroke; Heart Attacks; Myocardial Infarct; Myocardial Infarctions; cardiovascular strokes; heart attack; myocardial infarcts
narrow_synonym: MCI1; MCI2; post-operative myocardial infarction
broad_synonym: F7-RELATED CONDITION
related_synonym: MYOCARDIAL INFARCTION, DECREASED SUSCEPTIBILITY TO; MYOCARDIAL INFARCTION, PROTECTION AGAINST; MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO; MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 1; MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2
primary_id: MESH:D009203
alt_id: MIM:608446 ; MIM:608557
xref: EFO:0000612 ; EFO:0009953 ; NCI:C27996
For additional species annotation, visit the
Alliance of Genome Resources .
G
Abcc9
ATP-binding cassette, sub-family C member 9
ISO
ClinVar Annotator: match by term: Myocardial infarction
ClinVar
PMID:16563363 PMID:18239147 PMID:20474083 PMID:21846889 PMID:23739550 PMID:23861362 PMID:24033266 PMID:24439875 PMID:25333069 PMID:25741868 PMID:26636822 PMID:26656175 PMID:26764160 PMID:28492532 More...
NCBI chr 6:142,533,592...142,648,472
Ensembl chr 6:142,533,588...142,648,041
G
Ace
angiotensin I converting enzyme
treatment susceptibility
ISO
associated with Myocardial Reperfusion Injury ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism associated with Diabetes Mellitus, Type 1;DNA:deletion:intron:IVS16+1464-1751del (human)
ClinVar CTD RGD
PMID:1313972 PMID:1319114 PMID:1328889 PMID:1386652 PMID:1976655 PMID:2847529 PMID:2849100 PMID:7593601 PMID:7729604 PMID:7783416 PMID:7854377 PMID:7909524 PMID:8131299 PMID:8131300 PMID:8136829 PMID:8170965 PMID:8208911 PMID:8298638 PMID:8314010 PMID:8541160 PMID:8644984 PMID:8675669 PMID:9120002 PMID:9236417 PMID:9259580 PMID:9699903 PMID:9737775 PMID:9916793 PMID:10099885 PMID:10636736 PMID:10643899 PMID:10841123 PMID:11687636 PMID:11956052 PMID:12220450 PMID:12666117 PMID:14657821 PMID:14872014 PMID:15110771 PMID:15277638 PMID:15381116 PMID:15531537 PMID:15534175 PMID:15635071 PMID:19221299 PMID:25741868 PMID:28492532 PMID:21975128 PMID:23959549 PMID:15671045 PMID:15118671 PMID:7555560 More...
RGD:6893480 , RGD:9685449 , RGD:1558664 , RGD:1331525 , RGD:7829785
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ace2
angiotensin converting enzyme 2
treatment
ISO
RGD
PMID:15671045 PMID:23959549
RGD:1558664 , RGD:9685449
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Acta2
actin alpha 2, smooth muscle, aorta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
G
Acvr2a
activin receptor IIA
IEP
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 2:48,704,121...48,793,276
Ensembl chr 2:48,704,121...48,793,281
G
Acvr2b
activin receptor IIB
IEP
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 9:119,231,081...119,271,214
Ensembl chr 9:119,231,184...119,264,061
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif 1
ISO
RGD
PMID:15625312
RGD:9681751
NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001
G
Add1
adducin 1
no_association
ISO
DNA:missense mutation:cds:p.G460W (human)
RGD
PMID:17082469 PMID:16420563
RGD:5147995 , RGD:5148001
NCBI chr 5:34,731,008...34,789,652
Ensembl chr 5:34,731,008...34,789,652
G
Adipoq
adiponectin, C1Q and collagen domain containing
disease_progression
ISO
RGD
PMID:21326342
RGD:5686351
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adipor1
adiponectin receptor 1
IEP
mRNA, protein:decreased expression:heart left ventricle
RGD
PMID:16415076
RGD:1625764
NCBI chr 1:134,343,116...134,361,089
Ensembl chr 1:134,343,116...134,361,089
G
Adipor2
adiponectin receptor 2
IEP
mRNA, protein:decreased expression:heart left ventricle
RGD
PMID:16415076
RGD:1625764
NCBI chr 6:119,330,111...119,394,489
Ensembl chr 6:119,330,111...119,394,665
G
Adora1
adenosine A1 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12160945
NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169
G
Adora3
adenosine A3 receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12160945 PMID:20132822
NCBI chr 3:105,811,737...105,816,244
Ensembl chr 3:105,778,174...105,816,242
G
Adra2b
adrenergic receptor, alpha 2b
ISO
RGD
PMID:12535806
RGD:1559314
NCBI chr 2:127,205,099...127,209,141
Ensembl chr 2:127,205,128...127,209,141
G
Adrb1
adrenergic receptor, beta 1
ISO
GAD RGD
PMID:15118671 PMID:17143192
RGD:1331525 , RGD:7241557
NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545
G
Adrb2
adrenergic receptor, beta 2
susceptibility
ISO
DNA:polymorphisms: :p.G16R, p.Q27E, p.T164I mRNA:decreased expression:heart
RGD
PMID:15520258 PMID:12400771
RGD:1601126 , RGD:8548519
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
G
Ager
advanced glycosylation end product-specific receptor
susceptibility
ISO
mRNA:increased expression:left ventricle myocardium (rat) DNA:polymorphism:promoter:-429T>C (human)
RGD
PMID:19910580 PMID:16728681
RGD:2325647 , RGD:1625333
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Agt
angiotensinogen
susceptibility
ISO
associated with hypertension;DNA:polymorphism: :p.M235T associated with Coronary Artery Disease;DNA:polymorphism: :p.M235T (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:1668233 PMID:16413583 PMID:17299437 PMID:21167013 PMID:11393670 PMID:15118671 More...
RGD:1601132 , RGD:5129191 , RGD:1566452 , RGD:1331525
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Agtr1a
angiotensin II receptor, type 1a
no_association susceptibility
ISO
DNA:polymorphism:3' utr:1166A>C (human)
RGD GAD
PMID:9857918 PMID:9652322 PMID:15118671 PMID:16061119
RGD:1566499 , RGD:10047101 , RGD:1331525 , RGD:1601150
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
Ahsg
alpha-2-HS-glycoprotein
ISO
protein:increased expression:plasma
RGD
PMID:19029462
RGD:2313810
NCBI chr16:22,710,793...22,718,193
Ensembl chr16:22,710,027...22,718,199
G
Aimp1
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
ISO
RGD
PMID:14732363
RGD:1580021
NCBI chr 3:132,366,259...132,390,151
Ensembl chr 3:132,366,242...132,390,131
G
Ak1
adenylate kinase 1
treatment
ISO
RGD
PMID:22229508
RGD:11100025
NCBI chr 2:32,511,770...32,525,070
Ensembl chr 2:32,511,770...32,525,070
G
Akt1
thymoma viral proto-oncogene 1
ISO
protein:increased serine phosphorylation:platelet protein:decreased serine phosphorylation:heart
RGD
PMID:20467748 PMID:20352476
RGD:5509094 , RGD:10041035
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
ISO
DNA:missense mutation: :p.E487K (human)
RGD
PMID:12452318
RGD:2311152
NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
no_association
ISO
DNA:snps:multiple (human)
RGD GAD
PMID:14770184 PMID:15118671 PMID:19046748
RGD:1578317 , RGD:1331525 , RGD:2313891
NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
G
Ang
angiogenin, ribonuclease, RNase A family, 5
ISO
RGD
PMID:18462761
RGD:2325719
NCBI chr14:51,328,607...51,339,462
Ensembl chr14:51,328,607...51,339,466
G
Angpt1
angiopoietin 1
ISO
mRNA, protein:decreased expression:myocardium
RGD
PMID:15364619
RGD:1626168
NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373
G
Angpt2
angiopoietin 2
ISO
protein:increased expression:left ventricular wall, heart septum (rat)
RGD
PMID:16714360
RGD:1601493
NCBI chr 8:18,740,279...18,791,578
Ensembl chr 8:18,740,279...18,791,578
G
Anxa5
annexin A5
susceptibility no_association
ISO
DNA:polymorphism: :-1C>T (human) protein:altered localization:cardiac muscle cell, sarcolemma protein:increased expression:plasma
RGD
PMID:12200370 PMID:16501019 PMID:8814351 PMID:16025836
RGD:2317542 , RGD:2317541 , RGD:2317543 , RGD:1578384
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
G
Apex1
apurinic/apyrimidinic endonuclease 1
susceptibility
ISO
DNA:polymorphism:exon 5: G>A (human)
RGD
PMID:18712175
RGD:401827276
NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
G
Apoa1
apolipoprotein A-I
no_association
ISO
DNA:polymorphisms
RGD GAD
PMID:20176799 PMID:10428310 PMID:15118671
RGD:2325759 , RGD:1578442 , RGD:1331525
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Apoa4
apolipoprotein A-IV
no_association susceptibility
ISO
DNA:mutation:intron:IVS2 (human) associated with Diabetes Mellitus, Type 2; DNA:missense mutation:cds:p.Q360H (human)
RGD GAD
PMID:10428310 PMID:15118671 PMID:7958503
RGD:1578442 , RGD:1331525 , RGD:5685678
NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
G
Apob
apolipoprotein B
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr12:8,027,629...8,066,839
Ensembl chr12:8,027,648...8,066,835
G
Apoc3
apolipoprotein C-III
no_association
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
ClinVar RGD
PMID:10428310 PMID:15118671
RGD:1578442 , RGD:1331525
NCBI chr 9:46,144,348...46,146,934
Ensembl chr 9:46,144,231...46,146,934
G
Apoe
apolipoprotein E
susceptibility
ISO
DNA:missense mutations, haplotypes:cds:p.C112R, p.R158C (human) CTD Direct Evidence: marker/mechanism DNA:missense mutations, haplotype:cds:p.C112R, p.C158R (human)
CTD RGD
PMID:10587578 PMID:17217375 PMID:10090925 PMID:15118671
RGD:1601229 , RGD:10449412 , RGD:1331525
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Apoh
apolipoprotein H
ISO
RGD
PMID:15322656 PMID:12826288
RGD:2313985 , RGD:10054111
NCBI chr11:108,286,123...108,305,222
Ensembl chr11:108,234,180...108,305,222
G
Atg7
autophagy related 7
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
G
Atm
ataxia telangiectasia mutated
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:24358288 PMID:24358288
RGD:10053570
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
G
Atp1a1
ATPase, Na+/K+ transporting, alpha 1 polypeptide
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29702141
NCBI chr 3:101,483,535...101,512,023
Ensembl chr 3:101,483,535...101,512,000
G
Atp5f1d
ATP synthase F1 subunit delta
treatment
ISO
protein:decreased expression:myocardium (rat)
RGD
PMID:29300489 PMID:23809007
RGD:13792656 , RGD:13792681
NCBI chr10:79,974,451...79,981,662
Ensembl chr10:79,974,466...79,981,652
G
Atp5po
ATP synthase peripheral stalk subunit OSCP
treatment
IDA
RGD
PMID:24692845
RGD:13801194
NCBI chr16:91,722,111...91,728,518
Ensembl chr16:91,722,102...91,728,575 Ensembl chr16:91,722,102...91,728,575
G
Avpr1a
arginine vasopressin receptor 1A
ISO
RGD
PMID:16423716
RGD:2300376
NCBI chr10:122,284,404...122,289,358
Ensembl chr10:122,284,404...122,289,357
G
Bak1
BCL2-antagonist/killer 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29122578
NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983
G
Bax
BCL2-associated X protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20079142 PMID:25450231
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l1
BCL2-like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20079142 PMID:17467744
RGD:1643494
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bdkrb1
bradykinin receptor, beta 1
ISO
mRNA:increased expression:heart
RGD
PMID:12489796
RGD:704379
NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687
G
Bdkrb2
bradykinin receptor, beta 2
ISO
mRNA:increased expression:heart
RGD
PMID:12489796
RGD:704379
NCBI chr12:105,529,431...105,561,503
Ensembl chr12:105,529,485...105,561,496
G
Becn1
beclin 1, autophagy related
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20079142 PMID:20079142
RGD:11561913
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Birc5
baculoviral IAP repeat-containing 5
ISO
RGD
PMID:15081314
RGD:2293137
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
Bnip3
BCL2/adenovirus E1B interacting protein 3
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
G
Brap
BRCA1 associated protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198608
NCBI chr 5:121,798,626...121,825,312
Ensembl chr 5:121,798,626...121,825,319
G
Brinp3
bone morphogenetic protein/retinoic acid inducible neural specific 3
susceptibility
ISO
DNA:SNPs:3' end:
RGD
PMID:18430236
RGD:14398488
NCBI chr 1:146,371,367...146,778,210
Ensembl chr 1:146,370,498...146,778,210
G
C3
complement component 3
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:16996480
RGD:1600605
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
C7
complement component 7
ISO
Protein:increased activity:serum, myocardium
RGD
PMID:15724448
RGD:1599522
NCBI chr15:5,017,232...5,093,230
Ensembl chr15:5,018,244...5,093,222
G
C8a
complement component 8, alpha polypeptide
ISO
RGD
PMID:7515561
RGD:1600501
NCBI chr 4:104,672,876...104,733,684
Ensembl chr 4:104,672,876...104,733,595
G
C8b
complement component 8, beta subunit
ISO
RGD
PMID:7515561
RGD:1600501
NCBI chr 4:104,623,514...104,661,745
Ensembl chr 4:104,623,514...104,661,745
G
Cacybp
calcyclin binding protein
ISO
mRNA:increased expression:heart
RGD
PMID:16440310
RGD:2326117
NCBI chr 1:160,029,171...160,040,391
Ensembl chr 1:160,029,937...160,040,445
G
Camk2d
calcium/calmodulin-dependent protein kinase II, delta
treatment
ISO
mRNA, protein:splice variants, increased expression:heart left ventricle (rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr 3:126,389,136...126,639,975
Ensembl chr 3:126,389,951...126,639,975
G
Casp1
caspase 1
severity ameliorates
IMP ISO
RGD
PMID:17303764 PMID:33389498
RGD:2315913 , RGD:242905187
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
G
Casp3
caspase 3
ameliorates treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:25450231 PMID:28622474 PMID:27904666
RGD:329333030 , RGD:13782309
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casr
calcium-sensing receptor
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:22527939
RGD:7205672
NCBI chr16:36,310,947...36,382,605
Ensembl chr16:36,314,058...36,382,503
G
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21600015 PMID:14575298
RGD:1581148
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cav3
caveolin 3
ISO
Protein:increased expression:cytosol mRNA, protein; increased expression; myocardium (rat)
RGD
PMID:12566108 PMID:29438664
RGD:1599542 , RGD:126925221
NCBI chr 6:112,436,466...112,449,833
Ensembl chr 6:112,436,466...112,449,833
G
Ccl2
C-C motif chemokine ligand 2
treatment
ISO
protein:increased expression:serum DNA:snp:promoter:g.-2518A>G (human)
RGD
PMID:18459941 PMID:18753699 PMID:16116069
RGD:2307033 , RGD:8549616 , RGD:1581161
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl5
C-C motif chemokine ligand 5
ISO
mRNA:increased expression:heart (rat)
RGD
PMID:18954648
RGD:4890013
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccn1
cellular communication network factor 1
IEP ISO
mRNA,protein:increased expression:myocardium (mouse) mRNA,protein:increased expression:left ventricle myocardium (human)
RGD
PMID:15117851 PMID:15117851
RGD:329845570 , RGD:329845570
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
G
Ccn2
cellular communication network factor 2
treatment
ISO
mRNA:increased expression:left ventricle (rat)
RGD
PMID:18167060 PMID:29849775
RGD:2314623 , RGD:35673318
NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581
G
Ccna2
cyclin A2
ISO
protein:increased expression:cardiomyocyte:
RGD
PMID:23634243
RGD:10054471
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
G
Ccr2
C-C motif chemokine receptor 2
ISO
RGD
PMID:12853162 PMID:12719858
RGD:1581174 , RGD:1581177
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
G
Ccr3
C-C motif chemokine receptor 3
ISO
RGD
PMID:18954648
RGD:4890013
NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
G
Cct7
chaperonin containing TCP1 subunit 7
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1
ClinVar
PMID:24213632
NCBI chr 6:85,428,487...85,445,459
Ensembl chr 6:85,428,496...85,445,457
G
Cd14
CD14 antigen
no_association
ISO
associated with Coronary Artery Disease;DNA:SNP:promoter
RGD
PMID:14587643 PMID:10195920 PMID:17436151
RGD:1580255 , RGD:1580252 , RGD:2314155
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
G
Cd36
CD36 molecule
severity
ISO
RGD
PMID:22128087
RGD:6893560
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Cd40lg
CD40 ligand
ISO
protein:increased expression:serum
RGD
PMID:17635572
RGD:2314209
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
G
Cd59b
CD59b antigen
ISO
protein:decreased expression:myocardium
RGD
PMID:7515561
RGD:1600501
NCBI chr 2:103,900,127...103,920,619
Ensembl chr 2:103,896,142...103,921,534
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
treatment
ISO IMP
RGD
PMID:22492676 PMID:22492676
RGD:10045366 , RGD:10045366
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
G
Cfl1
cofilin 1, non-muscle
treatment
ISO
RGD
PMID:24292258
RGD:11570534
NCBI chr19:5,540,483...5,544,059
Ensembl chr19:5,540,483...5,545,229
G
Cftr
cystic fibrosis transmembrane conductance regulator
IMP
associated with Myocardial Reperfusion Injury
RGD
PMID:23221371
RGD:11566046
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
Chi3l1
chitinase 3 like 1
ISO
protein:increased secretion:serum (human)
RGD
PMID:18480670
RGD:4892633
NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919
G
Ciita
class II transactivator
susceptibility no_association
ISO
DNA:polymorphism:promoter:-168A>G (human)
RGD
PMID:15821736 PMID:17183695
RGD:1358146 , RGD:5491201
NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
G
Ckb
creatine kinase, brain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12359538
NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772
G
Ckm
creatine kinase, muscle
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3279722 PMID:12359538
NCBI chr 7:19,145,019...19,155,508
Ensembl chr 7:19,138,701...19,156,766
G
Clu
clusterin
treatment
ISO
RGD
PMID:20854280
RGD:9068409
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Col1a1
collagen, type I, alpha 1
treatment
ISO
RGD
PMID:25636075
RGD:11041598
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col3a1
collagen, type III, alpha 1
treatment
ISO
RGD
PMID:25636075
RGD:11041598
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
G
Col4a1
collagen, type IV, alpha 1
susceptibility
ISO
DNA:polymorphism: :p.Q1334H (human)
RGD
PMID:18077766
RGD:2311341
NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826
G
Col6a3
collagen, type VI, alpha 3
ISO
DNA:SNP:CDS:E1386K (rs146092501) (human)
RGD
PMID:30226566
RGD:401851058
NCBI chr 1:90,694,582...90,771,710
Ensembl chr 1:90,693,645...90,771,693
G
Creb1
cAMP responsive element binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Crem
cAMP responsive element modulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr18:3,263,181...3,337,688
Ensembl chr18:3,266,048...3,337,748
G
Crp
C-reactive protein, pentraxin-related
ISO
protein:increased expression:serum associated with Angina, Unstable;
RGD
PMID:21046814 PMID:9761079 PMID:22446866
RGD:5131456 , RGD:9491780 , RGD:6482304
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Cs
citrate synthase
severity
ISO IEP
protein:decreased expression:diaphragm, mitochondrion
RGD
PMID:1877670 PMID:34416105
RGD:243048469 , RGD:243048471
NCBI chr10:128,173,596...128,198,351
Ensembl chr10:128,173,603...128,198,348
G
Csf2
colony stimulating factor 2 (granulocyte-macrophage)
ISO
RGD
PMID:21326109
RGD:5131507
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
G
Csf3
colony stimulating factor 3 (granulocyte)
treatment
ISO
RGD
PMID:15639484
RGD:11039417
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Csnk2a1
casein kinase 2, alpha 1 polypeptide
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr 2:152,068,468...152,123,772
Ensembl chr 2:152,068,759...152,123,772
G
Csnk2b
casein kinase 2, beta polypeptide
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr17:35,335,171...35,341,029
Ensembl chr17:35,335,172...35,341,029
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
ISO
DNA:SNP:CDS:49A>G (human)
RGD
PMID:17652883
RGD:2301976
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
G
Ctsb
cathepsin B
ISO
protein:increased activity:serum, heart (rat)
RGD
PMID:19958779
RGD:2315501
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
G
Cxcl12
C-X-C motif chemokine ligand 12
ISO
mRNA:increased expression:heart left ventricle
RGD
PMID:19187644 PMID:11820456
RGD:2306567 , RGD:632503
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cyba
cytochrome b-245, alpha polypeptide
ISO
mRNA:increased expression:myocardium mRNA:increase expression:ventricle myocardium:
RGD
PMID:18762777 PMID:11243862
RGD:2317860 , RGD:1599690
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
G
Cybb
cytochrome b-245, beta polypeptide
ISO
mRNA:increase expression:ventricle myocardium
RGD
PMID:11243862
RGD:1599690
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
G
Cyp11b2
cytochrome P450, family 11, subfamily b, polypeptide 2
ISO
RGD
PMID:18689429
RGD:2307303
NCBI chr15:74,722,467...74,728,080
Ensembl chr15:74,722,859...74,728,167
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Cyp2j6
cytochrome P450, family 2, subfamily j, polypeptide 6
susceptibility
ISO
DNA:polymorphism
RGD
PMID:17126841
RGD:1625380
NCBI chr 4:96,404,375...96,449,835
Ensembl chr 4:96,404,375...96,441,898
G
Cyp2j9
cytochrome P450, family 2, subfamily j, polypeptide 9
susceptibility
ISO
DNA:polymorphism
RGD
PMID:17126841
RGD:1625380
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
G
Cyp2r1
cytochrome P450, family 2, subfamily r, polypeptide 1
ISO
DNA:SNP:CDS:rs2060793, rs1993116, rs10766197 (human)
RGD
PMID:29804528
RGD:401901167
NCBI chr 7:114,149,358...114,162,283
Ensembl chr 7:114,148,917...114,162,207
G
Dab2
disabled 2, mitogen-responsive phosphoprotein
ISO
protein:increased expression:cardiomyocyte
RGD
PMID:21762377 PMID:20666606
RGD:7243156 , RGD:7243158
NCBI chr15:6,329,269...6,470,196
Ensembl chr15:6,329,269...6,470,193
G
Dab2ip
disabled 2 interacting protein
onset
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:CDS:intron 1 (rs7025486) (human)
CTD RGD
PMID:20622881 PMID:20622881
RGD:401901599
NCBI chr 2:35,448,285...35,621,006
Ensembl chr 2:35,448,278...35,621,006
G
Dag1
dystroglycan 1
treatment
ISO
RGD
PMID:12034665
RGD:11541047
NCBI chr 9:108,082,060...108,141,176
Ensembl chr 9:108,081,833...108,141,157
G
Dcn
decorin
ISO
RGD
PMID:16311904
RGD:1598497
NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005
G
Ddit3
DNA-damage inducible transcript 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25450231
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Dgkz
diacylglycerol kinase zeta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17071729
NCBI chr 2:91,763,167...91,806,788
Ensembl chr 2:91,763,169...91,806,209
G
Dvl1
dishevelled segment polarity protein 1
ISO
RGD
PMID:15256074
RGD:1580899
NCBI chr 4:155,931,829...155,943,760
Ensembl chr 4:155,931,859...155,943,760
G
Dyrk1a
dual-specificity tyrosine phosphorylation regulated kinase 1a
treatment
ISO
associated with heart failure; protein:increased expression, increased activity:heart left ventricle (rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr16:94,370,770...94,496,378
Ensembl chr16:94,370,869...94,496,376
G
Ece1
endothelin converting enzyme 1
ISO
RGD
PMID:9607404
RGD:1580912
NCBI chr 4:137,589,548...137,692,540
Ensembl chr 4:137,589,548...137,692,540
G
Edn1
endothelin 1
severity
ISO
protein:increased secretion:plasma (human) mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:17893002 PMID:10573185
RGD:4144880 , RGD:1580921
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Edn2
endothelin 2
ISO
RGD
PMID:10573185
RGD:1580921
NCBI chr 4:120,018,403...120,024,557
Ensembl chr 4:120,018,403...120,024,557
G
Ednra
endothelin receptor type A
ISO
RGD
PMID:12524016
RGD:1580948
NCBI chr 8:78,389,658...78,451,081
Ensembl chr 8:78,389,660...78,451,093
G
Ednrb
endothelin receptor type B
ISO
RGD
PMID:12524016
RGD:1580948
NCBI chr14:104,052,055...104,081,764
Ensembl chr14:104,052,061...104,081,838
G
Egln1
egl-9 family hypoxia-inducible factor 1
ISO
RGD
PMID:16765982
RGD:11252084
NCBI chr 8:125,635,325...125,676,063
Ensembl chr 8:125,635,326...125,676,063
G
Egln3
egl-9 family hypoxia-inducible factor 3
ISO
RGD
PMID:16765982
RGD:11252084
NCBI chr12:54,225,767...54,250,660
Ensembl chr12:54,225,767...54,250,646
G
Epas1
endothelial PAS domain protein 1
ISO
RGD
PMID:15247145 PMID:18484163
RGD:1580977 , RGD:5147886
NCBI chr17:87,061,292...87,140,838
Ensembl chr17:87,061,128...87,140,838
G
Ephb1
Eph receptor B1
ameliorates
ISO
RGD
PMID:28622474
RGD:329333030
NCBI chr 9:101,799,327...102,231,892
Ensembl chr 9:101,799,327...102,231,892
G
Ephx2
epoxide hydrolase 2, cytoplasmic
IMP
RGD
PMID:19716829
RGD:5688358
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
G
Epo
erythropoietin
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19337937 PMID:21415704
RGD:10400907
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Epor
erythropoietin receptor
ISO
RGD
PMID:21415704
RGD:10400907
NCBI chr 9:21,870,193...21,874,915
Ensembl chr 9:21,870,193...21,874,802
G
Erbb2
erb-b2 receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:26892146
RGD:11522702
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
G
Erbb4
erb-b2 receptor tyrosine kinase 4
treatment
ISO
RGD
PMID:26892146
RGD:11522702
NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218
G
Esr1
estrogen receptor 1 (alpha)
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:11894143 PMID:11919305 PMID:14600184 PMID:15133719 PMID:25741868 PMID:15118671 More...
RGD:1331525
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
F10
coagulation factor X
ISO
ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to
ClinVar
PMID:10984565 PMID:12181036 PMID:25741868
NCBI chr 8:13,087,308...13,106,676
Ensembl chr 8:13,087,308...13,106,676
G
F12
coagulation factor XII (Hageman factor)
susceptibility
ISO
DNA:polymorphism:promoter:-46C>T(human)
RGD
PMID:16411408
RGD:11041803
NCBI chr13:55,565,771...55,574,617
Ensembl chr13:55,565,771...55,574,606
G
F13a1
coagulation factor XIII, A1 subunit
ISO
ClinVar Annotator: match by term: Myocardial infarction, protection against CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD RGD
PMID:8025280 PMID:9459313 PMID:9550516 PMID:10365735 PMID:10910914 PMID:12072871 PMID:12456499 PMID:17393027 PMID:25741868 PMID:12480694 More...
RGD:1581022
NCBI chr13:37,051,150...37,234,220
Ensembl chr13:37,051,152...37,234,220
G
F2
coagulation factor II
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism::20210G>A(human)
CTD RGD
PMID:9292507 PMID:9531249 PMID:10027711 PMID:12480694
RGD:1581022
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F3
coagulation factor III
treatment
ISO
RGD
PMID:21229253
RGD:11062083
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
F5
coagulation factor V
no_association susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:mutation:cds:1691G>A (human)
CTD RGD
PMID:9531249 PMID:10590188 PMID:15131548
RGD:11564337 , RGD:11564335
NCBI chr 1:163,979,396...164,048,539
Ensembl chr 1:163,979,407...164,047,846
G
F7
coagulation factor VII
susceptibility
ISO
protein:increased activity:plasma (human) ClinVar Annotator: match by term: F7-related condition | ClinVar Annotator: match by term: Myocardial infarction, decreased susceptibility to | ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism DNA:missense mutation, repeat:cds, intron:p.R353Q, (human)
OMIM ClinVar CTD RGD
PMID:1634227 PMID:2070047 PMID:6812354 PMID:7919338 PMID:7981691 PMID:8242057 PMID:8844208 PMID:8883260 PMID:10554827 PMID:10862079 PMID:10984565 PMID:11129332 PMID:11931672 PMID:12181036 PMID:12903033 PMID:12935978 PMID:15142120 PMID:15456489 PMID:15735798 PMID:18282149 PMID:18669152 PMID:18976247 PMID:20040857 PMID:20735728 PMID:20958793 PMID:21902896 PMID:22180436 PMID:25582404 PMID:25741868 PMID:25828579 PMID:25952977 PMID:26105150 PMID:28492532 PMID:31064749 PMID:34355501 PMID:7495060 PMID:9420338 PMID:16116695 More...
RGD:2312409 , RGD:11049521 , RGD:1580374
NCBI chr 8:13,075,499...13,085,809
Ensembl chr 8:13,076,034...13,085,809
G
Fabp3
fatty acid binding protein 3, muscle and heart
ISO
RGD
PMID:8326460
RGD:1582401
NCBI chr 4:130,202,531...130,209,256
Ensembl chr 4:130,202,388...130,209,256
G
Fgb
fibrinogen beta chain
ISO
RGD GAD
PMID:9437197 PMID:15118671
RGD:1580381 , RGD:1331525
NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170
G
Fgf1
fibroblast growth factor 1
treatment
ISO
RGD
PMID:24200746
RGD:10449026
NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525
G
Fgfr1
fibroblast growth factor receptor 1
IEP
RGD
PMID:17439742
RGD:10402087
NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
G
Fgfr2
fibroblast growth factor receptor 2
ameliorates
IMP
RGD
PMID:19358330
RGD:155663664
NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079
G
Fis1
fission, mitochondrial 1
ISO
protein:increased expression:plantaris (rat)
RGD
PMID:24427319
RGD:11557988
NCBI chr 5:136,982,129...136,995,088
Ensembl chr 5:136,982,129...136,995,088
G
Flt1
FMS-like tyrosine kinase 1
ISO
RGD
PMID:16714360
RGD:1601493
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
G
Flt3l
FMS-like tyrosine kinase 3 ligand
treatment
IDA
RGD
PMID:24184252
RGD:11049498
NCBI chr 7:44,780,607...44,785,914
Ensembl chr 7:44,779,212...44,785,856
G
Fn1
fibronectin 1
ISO
protein:decreased expression:heart
RGD
PMID:19695229
RGD:2325720
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
G
Fos
FBJ osteosarcoma oncogene
ISO
protein:increased expression:paraventricular nucleus hypothalamus, paraventricular nucleus thalamus
RGD
PMID:27601012
RGD:405649741
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Fto
FTO alpha-ketoglutarate dependent dioxygenase
treatment
IEP ISO IMP
mRNA, protein:decreased expression:heart DNA:SNP: :rs17817449 (human) associated with type 2 diabetes mellitus;DNA:SNP:intron:rs9939609 (human)
RGD
PMID:29997116 PMID:26772723 PMID:20031593 PMID:29997116
RGD:329812009 , RGD:11555187 , RGD:329901766 , RGD:329812009
NCBI chr 8:92,039,995...92,395,061
Ensembl chr 8:92,040,153...92,395,067
G
Fzd2
frizzled class receptor 2
ISO
mRNA:increased expression:heart left ventricle
RGD
PMID:9142123
RGD:4107058
NCBI chr11:102,495,257...102,498,884
Ensembl chr11:102,495,222...102,498,884
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
treatment
ISO
RGD
PMID:20462747
RGD:10449173
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gata4
GATA binding protein 4
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:20200331 PMID:23948075
RGD:7327215
NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141
G
Gatm
glycine amidinotransferase (L-arginine:glycine amidinotransferase)
IEP
RGD
PMID:31972362
RGD:329961305
NCBI chr 2:122,424,954...122,441,758
Ensembl chr 2:122,424,948...122,441,784
G
Gch1
GTP cyclohydrolase 1
treatment
ISO
RGD
PMID:32782412 PMID:26192027
RGD:329961570 , RGD:329970290
NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870
G
Gclc
glutamate-cysteine ligase, catalytic subunit
susceptibility
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism DNA:snp:promoter:c.-129C>T (human)
ClinVar OMIM CTD RGD
PMID:12598062 PMID:12598062
RGD:1302515
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gclm
glutamate-cysteine ligase, modifier subunit
susceptibility
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:12081989 PMID:12975258
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Ggt1
gamma-glutamyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19419996
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Gh
growth hormone
treatment
ISO
RGD
PMID:12500159
RGD:11352745
NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691
G
Ghrh
growth hormone releasing hormone
treatment
ISO
RGD
PMID:24373935
RGD:10401242
NCBI chr 2:157,171,416...157,190,645
Ensembl chr 2:157,171,417...157,189,426
G
Gja1
gap junction protein, alpha 1
treatment
ISO
protein:decreased phosphorylation
RGD
PMID:22969867 PMID:29428663 PMID:22841862
RGD:7207261 , RGD:13592597 , RGD:7207262
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
G
Gja4
gap junction protein, alpha 4
ISO
RGD
PMID:15982495
RGD:1580400
NCBI chr 4:127,205,213...127,207,832
Ensembl chr 4:127,205,214...127,207,832
G
Gja5
gap junction protein, alpha 5
treatment
ISO
RGD
PMID:29428663
RGD:13592597
NCBI chr 3:96,939,718...96,960,950
Ensembl chr 3:96,812,009...96,984,732
G
Gp1ba
glycoprotein 1b, alpha polypeptide
ISO
RGD
PMID:15269835
RGD:1580432
NCBI chr11:70,529,928...70,534,812
Ensembl chr11:70,529,948...70,532,862
G
Gp6
glycoprotein 6 (platelet)
sexual_dimorphism treatment no_association susceptibility onset
ISO
DNA:missense mutation:CDS:c.13254T>C (p.S219P) (human) human protein in a mouse model DNA:missense mutation:CDS:c.13254T>C (p.S219P) (rs1613662) (human) DNA:missense mutation:exon 7:c.645213C>T (p.T249A) (human) DNA:SNP, missense mutation:promoter, CDS:c.-148C>T, c.13254T>C (p.S219P) (human)
RGD
PMID:11571236 PMID:22814400 PMID:20723028 PMID:12417295 PMID:11571236 PMID:11571236 More...
RGD:401793749 , RGD:401824647 , RGD:401794407 , RGD:401793754 , RGD:401793749 , RGD:401793749
NCBI chr 7:4,365,852...4,400,849
Ensembl chr 7:4,366,964...4,400,743
G
Gpt
glutamic pyruvic transaminase, soluble
treatment
ISO
RGD
PMID:32026788
RGD:401793703
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Gpx1
glutathione peroxidase 1
susceptibility
ISO
RGD
PMID:14573732
RGD:1600662
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gsk3b
glycogen synthase kinase 3 beta
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16716347 PMID:16565311
RGD:10045368
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Gsn
gelsolin
ameliorates
ISO
protein:decreased expression:blood serum (human)
RGD
PMID:9142022 PMID:28622474
RGD:329333022 , RGD:329333030
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
G
Gsr
glutathione reductase
treatment
ISO
RGD
PMID:25119867
RGD:10401898
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gucy1a1
guanylate cyclase 1, soluble, alpha 1
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1
ClinVar
PMID:24213632
NCBI chr 3:81,999,734...82,053,253
Ensembl chr 3:81,999,734...82,053,096
G
H19
H19, imprinted maternally expressed transcript
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,131,917
G
Hadh
hydroxyacyl-Coenzyme A dehydrogenase
ISO
RGD
PMID:11481570
RGD:2302229
NCBI chr 3:131,027,068...131,065,750
Ensembl chr 3:131,027,068...131,065,750
G
Hamp
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:heart
RGD
PMID:19615879
RGD:11041636
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
G
Hfe
homeostatic iron regulator
no_association susceptibility
ISO
RGD
PMID:12850485 PMID:10491370
RGD:1582672 , RGD:1582697
NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837
G
Hgf
hepatocyte growth factor
treatment
ISO
protein:increased expression:serum:
RGD
PMID:12419930 PMID:16570015
RGD:8548609 , RGD:8548632
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
G
Hif1a
hypoxia inducible factor 1, alpha subunit
ameliorates treatment
ISO
mRNA:increased expression:heart left ventricle human gene in a rat model
RGD
PMID:18484163 PMID:28622474 PMID:15247145 PMID:15999059
RGD:5147886 , RGD:329333030 , RGD:1580977 , RGD:9068466
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hmgb1
high mobility group box 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:21113057 PMID:23188125
RGD:10402174
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hmox1
heme oxygenase 1
ISO
RGD
PMID:12392996 PMID:20925964
RGD:1598393 , RGD:4145134
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hp
haptoglobin
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16597321 PMID:17068284 PMID:17207726 PMID:3990081 PMID:2613263
RGD:1626360 , RGD:1626354
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
ameliorates
IMP
RGD
PMID:28522730 PMID:26465199
RGD:329902054 , RGD:11087531
NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
ISO
mRNA:increased expression:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17587755 PMID:17587755
RGD:2308939
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
G
Hspa5
heat shock protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25450231
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Hspd1
heat shock protein 1 (chaperonin)
ISO
RGD
PMID:17202668
RGD:1624230
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
G
Icam1
intercellular adhesion molecule 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10070497 PMID:23139358
RGD:8547733
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifna2
interferon alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3597002
NCBI chr 4:88,601,444...88,602,016
Ensembl chr 4:88,601,118...88,602,149
G
Igf1
insulin-like growth factor 1
severity
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:19295919 PMID:16635594
RGD:2306696 , RGD:1598421
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf1r
insulin-like growth factor I receptor
ISO
mRNA,protein:increased expression:myocyte:
RGD
PMID:8682060
RGD:10046050
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Il10
interleukin 10
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15883752 PMID:16310260 PMID:15466015
RGD:1598480
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il17a
interleukin 17A
ISO
mRNA, protein:increased expression:heart left ventricle (rat)
RGD
PMID:23096364
RGD:9095344
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il18
interleukin 18
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il18bp
interleukin 18 binding protein
ISO
RGD
PMID:19805173
RGD:4889400
NCBI chr 7:101,664,281...101,669,699
Ensembl chr 7:101,664,092...101,667,897
G
Il1b
interleukin 1 beta
ameliorates
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:11743230 PMID:15883752 PMID:16310260 PMID:23143013 PMID:33389498 PMID:23237935 More...
RGD:7175553 , RGD:242905187 , RGD:7204425
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:18474815 PMID:19005744
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il4ra
interleukin 4 receptor, alpha
ISO
mRNA:increased expression:heart
RGD
PMID:10807530
RGD:4889985
NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646
G
Il6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15883752 PMID:16310260
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Il6ra
interleukin 6 receptor, alpha
ISO
RGD
PMID:12123772
RGD:1625444
NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503
G
Inhba
inhibin beta-A
ISO IEP
mRNA:increased expression:heart (rat) mRNA:increased expression:myocardium (mouse)
RGD
PMID:14993131 PMID:32427381
RGD:1580888 , RGD:329849118
NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206
G
Inhbb
inhibin beta-B
IEP
mRNA:increased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 1:119,343,193...119,349,978
Ensembl chr 1:119,343,195...119,349,978
G
Isl1
ISL1 transcription factor, LIM/homeodomain
ameliorates
ISO IDA
RGD
PMID:29482621 PMID:22727192
RGD:243048463 , RGD:243048464
NCBI chr13:116,434,806...116,446,224
Ensembl chr13:116,434,817...116,446,225
G
Itga2
integrin alpha 2
susceptibility no_association
ISO
RGD
PMID:16697311 PMID:10194421 PMID:15227729
RGD:1582296 , RGD:1581029 , RGD:1582294
NCBI chr13:114,969,617...115,068,588
Ensembl chr13:114,969,617...115,068,636
G
Itga3
integrin alpha 3
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:19041328
RGD:2325287
NCBI chr11:94,935,301...94,967,637
Ensembl chr11:94,935,300...94,967,627
G
Itgam
integrin alpha M
treatment
IEP
RGD
PMID:29933226
RGD:329853753
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
G
Itgb1
integrin beta 1 (fibronectin receptor beta)
treatment
ISO
RGD
PMID:28367125
RGD:13602094
NCBI chr 8:129,412,135...129,460,060
Ensembl chr 8:129,412,135...129,459,681
G
Itgb3
integrin beta 3
no_association susceptibility
ISO
DNA:polymorphism:exon: ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism associated with arteriosclerosis; DNA:polymorphism:exon
OMIM ClinVar CTD RGD
PMID:2014236 PMID:7570918 PMID:8598867 PMID:8667943 PMID:8838346 PMID:9700201 PMID:10583927 PMID:10727448 PMID:11723016 PMID:17264806 PMID:25728920 PMID:25741868 PMID:28492532 PMID:9716140 PMID:10531147 PMID:20846430 More...
RGD:5128498 , RGD:5128481 , RGD:5128476
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
G
Itih4
inter alpha-trypsin inhibitor, heavy chain 4
ISO
RGD
PMID:10486281
RGD:1582334
NCBI chr14:30,608,433...30,623,943
Ensembl chr14:30,608,433...30,624,310
G
Jak2
Janus kinase 2
susceptibility
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:22749532
RGD:10403083
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
G
Kcnj2
potassium inwardly-rectifying channel, subfamily J, member 2
treatment
ISO
RGD
PMID:23647964
RGD:7247426
NCBI chr11:110,956,990...110,967,651
Ensembl chr11:110,956,990...110,967,647
G
Kcnk2
potassium channel, subfamily K, member 2
ISO
mRNA:decreased expression:heart left ventricle, epicardium, endocardium (rat)
RGD
PMID:21683547
RGD:9831182
NCBI chr 1:188,940,127...189,134,951
Ensembl chr 1:188,940,127...189,134,470
G
Kcnn4
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
susceptibility
ISO
DNA:SNPs,haplotypes:introns:multiple
RGD
PMID:19644414
RGD:329969896
NCBI chr 7:24,069,750...24,084,635
Ensembl chr 7:24,069,688...24,086,115
G
Kdm5b
lysine demethylase 5B
ameliorates
IMP
RGD
PMID:36481938
RGD:329901769
NCBI chr 1:134,487,916...134,560,621
Ensembl chr 1:134,487,909...134,563,023
G
Kdm6a
lysine (K)-specific demethylase 6A
ISO
mRNA:increased expression:myocardium (rat)
RGD
PMID:30887465
RGD:151665136
NCBI chr X:18,027,101...18,147,061
Ensembl chr X:18,028,814...18,146,175
G
Kdr
kinase insert domain protein receptor
treatment
ISO
RGD
PMID:16698275 PMID:25936512
RGD:1581717 , RGD:126925214
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Kif6
kinesin family member 6
no_association treatment
ISO
DNA:SNP: :rs20455 (human) DNA:SNP: :p.W719R (rs20455) (human)
RGD
PMID:18222354 PMID:20927332 PMID:26997531 PMID:19371834 PMID:20403483
RGD:243048446 , RGD:243048450 , RGD:243048449 , RGD:243048447 , RGD:11097528
NCBI chr17:49,922,121...50,216,875
Ensembl chr17:49,922,164...50,216,875
G
Klf13
Kruppel-like transcription factor 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29122578
NCBI chr 7:63,536,099...63,588,663
Ensembl chr 7:63,536,099...63,588,663
G
Klk1
kallikrein 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12411458
NCBI chr 7:43,874,784...43,879,046
Ensembl chr 7:43,874,784...43,879,042
G
Lamp2
lysosomal-associated membrane protein 2
ISO
mRNA:increased expression:plantaris
RGD
PMID:24427319
RGD:11557988
NCBI chr X:37,488,524...37,545,337
Ensembl chr X:37,490,234...37,545,331
G
Lcat
lecithin cholesterol acyltransferase
ISO
RGD
PMID:16640830
RGD:1581773
NCBI chr 8:106,666,183...106,670,034
Ensembl chr 8:106,666,183...106,670,014
G
Lcn2
lipocalin 2
ameliorates
IMP
RGD
PMID:27800610
RGD:126790572
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Ldha
lactate dehydrogenase A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:3279722
NCBI chr 7:46,491,698...46,505,051
Ensembl chr 7:46,490,899...46,505,051
G
Ldlr
low density lipoprotein receptor
ISO
GAD
PMID:15118671
RGD:1331525
NCBI chr 9:21,634,872...21,661,215
Ensembl chr 9:21,634,779...21,661,215
G
Lefty1
left right determination factor 1
ameliorates
IMP
RGD
PMID:33409963
RGD:401794430
NCBI chr 1:180,762,587...180,765,966
Ensembl chr 1:180,762,587...180,765,965
G
Lgals2
lectin, galactose-binding, soluble 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
OMIM CTD ClinVar RGD
PMID:15129282 PMID:15129282
RGD:1581852
NCBI chr15:78,735,060...78,739,729
Ensembl chr15:78,735,060...78,739,729
G
Lgals3
lectin, galactose binding, soluble 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29769800
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
G
Lipg
lipase, endothelial
susceptibility
ISO
DNA:polymorphism: :584C>T
RGD
PMID:17526978
RGD:1641818
NCBI chr18:75,072,393...75,095,380
Ensembl chr18:75,072,393...75,094,334
G
Lox
lysyl oxidase
IDA
RGD
PMID:14553832
RGD:1581883
NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
G
Lpl
lipoprotein lipase
susceptibility
ISO
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:SNP: :p.D9N (rs1801177) (human)
RGD
PMID:18823627
RGD:2313302
NCBI chr 8:69,333,207...69,359,584
Ensembl chr 8:69,333,143...69,360,100
G
Lrp1
low density lipoprotein receptor-related protein 1
susceptibility
ISO
RGD
PMID:12402342
RGD:1581913
NCBI chr10:127,374,026...127,457,158
Ensembl chr10:127,374,030...127,457,017
G
Lrp8
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
no_association susceptibility onset
ISO
DNA:missense mutation:cds:p.R952Q (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Myocardial infarction, susceptibility to, 1 DNA:missense mutation: :p.R952Q (human)
CTD OMIM ClinVar RGD
PMID:17847002 PMID:18592168 PMID:17847002
RGD:2306125 , RGD:2306124
NCBI chr 4:107,659,337...107,734,037
Ensembl chr 4:107,659,066...107,734,037
G
Lrpap1
low density lipoprotein receptor-related protein associated protein 1
susceptibility
ISO
RGD
PMID:12394648
RGD:1581922
NCBI chr 5:35,248,834...35,263,043
Ensembl chr 5:35,248,845...35,263,110
G
Lta
lymphotoxin A
no_association susceptibility severity
ISO
ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism DNA:SNP:exon:804C>A (p.T26N) (human)
ClinVar OMIM CTD RGD
PMID:12426569 PMID:12746914 PMID:14681301 PMID:15129282 PMID:15266304 PMID:25741868 PMID:15175864 PMID:23398946 PMID:12426569 More...
RGD:1581940 , RGD:8548841 , RGD:1580417
NCBI chr17:35,422,141...35,424,568
Ensembl chr17:35,422,141...35,424,327
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
treatment
ISO
RGD
PMID:20079142
RGD:11561913
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
treatment
ISO
RGD
PMID:22635076
RGD:10412335
NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
G
Map3k7
mitogen-activated protein kinase kinase kinase 7
treatment
ISO
mRNA, protein:increased expression:myocardium (rat)
RGD
PMID:16183734 PMID:27121011
RGD:2298758 , RGD:11073666
NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
G
Mapk1
mitogen-activated protein kinase 1
ISO
RGD
PMID:15653762
RGD:1582282
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk14
mitogen-activated protein kinase 14
ameliorates
IEP
RGD
PMID:33409963
RGD:401794430
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mapk8
mitogen-activated protein kinase 8
ameliorates
ISO
RGD
PMID:28622474
RGD:329333030
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mdh2
malate dehydrogenase 2, NAD (mitochondrial)
ISO
RGD
PMID:9753871
RGD:1582468
NCBI chr 5:135,807,503...135,819,240
Ensembl chr 5:135,807,334...135,819,252
G
Mdk
midkine
ISO
RGD
PMID:9568069
RGD:1582488
NCBI chr 2:91,760,149...91,762,348
Ensembl chr 2:91,760,150...91,762,642
G
Mef2c
myocyte enhancer factor 2C
treatment
ISO
RGD
PMID:23948075
RGD:7327215
NCBI chr13:83,652,136...83,815,197
Ensembl chr13:83,652,153...83,815,199
G
Meox2
mesenchyme homeobox 2
ISO
protein:decreased expression:heart (rat)
RGD
PMID:24155330
RGD:155882536
NCBI chr12:37,158,539...37,229,533
Ensembl chr12:37,158,539...37,229,533
G
Mesp1
mesoderm posterior 1
treatment
ISO
human gene and cell line in a rat model
RGD
PMID:32550911
RGD:242905196
NCBI chr 7:79,441,989...79,443,338
Ensembl chr 7:79,441,989...79,443,536
G
Mff
mitochondrial fission factor
treatment
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:23867156 PMID:23867156
RGD:12879458
NCBI chr 1:82,702,599...82,730,111
Ensembl chr 1:82,702,611...82,730,115
G
Mfn2
mitofusin 2
treatment
ISO
RGD
PMID:20886221
RGD:12738232
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
G
Mgp
matrix Gla protein
susceptibility
ISO
RGD
PMID:11073842
RGD:1582503
NCBI chr 6:136,849,433...136,852,821
Ensembl chr 6:136,849,433...136,852,821
G
Mia3
MIA SH3 domain ER export factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198609
NCBI chr 1:183,107,091...183,151,091
Ensembl chr 1:183,107,682...183,150,894
G
Miat
myocardial infarction associated transcript (non-protein coding)
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM
PMID:17066261
NCBI chr 5:112,361,094...112,376,814
Ensembl chr 5:112,361,094...112,377,261
G
Mif
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
ISO
protein:increased expression:plasma mRNA, protein:increased expression:myocardium
RGD
PMID:11589847 PMID:12704210
RGD:1642008 , RGD:1642003
NCBI chr10:75,695,187...75,696,111
Ensembl chr10:75,695,187...75,696,074
G
Mir125b-2
microRNA 125b-2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29122578
NCBI chr16:77,443,161...77,443,231
Ensembl chr16:77,443,161...77,443,231
G
Mir143
microRNA 143
IEP ISO
RNA:increased expression:myocardium: RNA:increased expression:plasma, left ventricle:
RGD
PMID:28887629 PMID:29728596
RGD:155882580 , RGD:155882581
NCBI chr18:61,782,267...61,782,329
Ensembl chr18:61,782,267...61,782,329
G
Mir145a
microRNA 145a
treatment ameliorates
ISO IEP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29956747 PMID:30146700 PMID:32890431
RGD:155260296 , RGD:155260294
NCBI chr18:61,780,896...61,780,965
Ensembl chr18:61,780,896...61,780,965
G
Mir155
microRNA 155
treatment
IMP
RGD
PMID:31207208
RGD:21066347
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir208a
microRNA 208a
treatment
IMP ISO
miRNA:increased expression:heart
RGD
PMID:26688617 PMID:26861724
RGD:11536862 , RGD:242905213
NCBI chr14:55,186,517...55,186,599
Ensembl chr14:55,186,517...55,186,599
G
Mir223
microRNA 223
ISO
RNA:increased expression:heart
RGD
PMID:29608885
RGD:21408565
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mir25
microRNA 25
IEP
RNA:increased expression:myocardium:
RGD
PMID:28887629
RGD:155882580
NCBI chr 5:138,163,583...138,163,666
Ensembl chr 5:138,163,583...138,163,666
G
Mir30a
microRNA 30a
treatment
ISO
RGD
PMID:29849775
RGD:35673318
NCBI chr 1:23,311,350...23,311,420
Ensembl chr 1:23,311,350...23,311,420
G
Mir30c-1
microRNA 30c-1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34217758
NCBI chr 4:120,626,731...120,626,819
Ensembl chr 4:120,626,731...120,626,819
G
Mir30e
microRNA 30e
ISO
miRNA:decreased expression:heart (rat)
RGD
PMID:25950484
RGD:11541106
NCBI chr 4:120,629,803...120,629,894
Ensembl chr 4:120,629,803...120,629,894
G
Mir320
microRNA 320
treatment
IMP
RGD
PMID:19380620
RGD:155882541
NCBI chr14:70,680,950...70,681,031
Ensembl chr14:70,680,950...70,681,031
G
Mir423
microRNA 423
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24253456
NCBI chr11:76,968,890...76,968,998
Ensembl chr11:76,968,890...76,968,998
G
Mir761
microRNA 761
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:23867156
NCBI chr 4:108,874,852...108,874,927
Ensembl chr 4:108,874,852...108,874,927
G
Mlxipl
MLX interacting protein-like
susceptibility
ISO
DNA:SNP:cd: C771G, p.Q241H (rs3812316) (human)
RGD
PMID:24448738
RGD:401799621
NCBI chr 5:135,118,744...135,168,622
Ensembl chr 5:135,118,744...135,167,236
G
Mmp13
matrix metallopeptidase 13
ISO
RGD
PMID:15782494
RGD:1582556
NCBI chr 9:7,272,514...7,283,333
Ensembl chr 9:7,272,514...7,283,331
G
Mmp14
matrix metallopeptidase 14 (membrane-inserted)
ISO
RGD
PMID:16461815
RGD:1582569
NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821
G
Mmp1a
matrix metallopeptidase 1a (interstitial collagenase)
susceptibility
ISO
protein:increased expression, increased activity:heart left ventricle (rat) human gene in rat model associated with Coronary Artery Disease; DNA:snps, haplotype:promoter:g.-519A>G, g.-340T>C (human)
RGD
PMID:15009768 PMID:8531210 PMID:11179039 PMID:19797822 PMID:16210545
RGD:1582535 , RGD:7207198 , RGD:7207136 , RGD:7207135 , RGD:1582520
NCBI chr 9:7,464,141...7,476,870
Ensembl chr 9:7,464,141...7,476,857
G
Mmp1b
matrix metallopeptidase 1b (interstitial collagenase)
susceptibility
ISO
associated with Coronary Artery Disease; DNA:snps, haplotype:promoter:g.-519A>G, g.-340T>C (human) protein:increased expression, increased activity:heart left ventricle (rat) human gene in rat model
RGD
PMID:8531210 PMID:11179039 PMID:15009768 PMID:16210545 PMID:19797822
RGD:1582520 RGD:1582535 RGD:7207135 RGD:7207136 RGD:7207198
NCBI chr 9:7,367,670...7,388,026
Ensembl chr 9:7,368,239...7,388,047
G
Mmp2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16310260 PMID:24358288 PMID:10773235 PMID:11179039
RGD:1582587 , RGD:7207136
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp3
matrix metallopeptidase 3
ISO
RGD
PMID:15467919
RGD:1580551
NCBI chr 9:7,445,845...7,455,975
Ensembl chr 9:7,445,822...7,455,975
G
Mmp7
matrix metallopeptidase 7
IAGP
RGD
PMID:16769909
RGD:1582373
NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,587
G
Mmp9
matrix metallopeptidase 9
susceptibility
ISO IEP IDA
protein:increased expression:coronary artery, plasma (human) protein:increased expression:heart left ventricle CTD Direct Evidence: marker/mechanism protein:increased expression, increased activity:heart left ventricle (rat) DNA:snps:promoter, exon:g.-1562C>T, p.R279Q (rs3918242, rs2664538) (human)
CTD RGD
PMID:16310260 PMID:24358288 PMID:15118287 PMID:25520329 PMID:8531210 PMID:17893005 PMID:16845718 PMID:14729404 More...
RGD:1582645 , RGD:13204799 , RGD:7207198 , RGD:7207049 , RGD:1582653 , RGD:1582639
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mstn
myostatin
IEP
mRNA:decreased expression:myocardium (mouse)
RGD
PMID:32427381
RGD:329849118
NCBI chr 1:53,100,799...53,107,238
Ensembl chr 1:53,100,799...53,107,238
G
mt-Nd2
NADH dehydrogenase 2, mitochondrial
ISO
DNA:missense mutation: :m.5178C>A (p.L237M) (human)
RGD
PMID:15262184
RGD:1581054
NCBI chr MT:3,914...4,951
Ensembl chr MT:3,914...4,951
G
Mthfr
methylenetetrahydrofolate reductase
susceptibility
ISO
associated with Kidney Failure, Chronic; DNA:transition:cds:g.677C>T rs1801133 (human) DNA:SNP: :677C>T (human)
RGD
PMID:19272686 PMID:10090925
RGD:6893548 , RGD:10449412
NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008
G
Mtor
mechanistic target of rapamycin kinase
treatment
ISO
protein:decreased serine phosphorylation:heart associated with Diabetes Mellitus, Experimental
RGD
PMID:20352476 PMID:23773982
RGD:10041035 , RGD:10041040
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
G
Myh6
myosin, heavy polypeptide 6, cardiac muscle, alpha
ISO
RGD
PMID:15090263
RGD:11565830
NCBI chr14:55,179,378...55,205,553
Ensembl chr14:55,179,378...55,204,384
G
Myh7
myosin, heavy polypeptide 7, cardiac muscle, beta
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11743230 PMID:15090263
RGD:11565830
NCBI chr14:55,208,141...55,232,083
Ensembl chr14:55,208,141...55,232,083
G
Ncam1
neural cell adhesion molecule 1
IEP ISO
mRNA, protein:increased expression:heart protein:alternative form, increased expression:myocardium
RGD
PMID:19853610 PMID:23462508
RGD:2325979 , RGD:40924663
NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225
G
Ndufb5
NADH:ubiquinone oxidoreductase subunit B5
treatment
IEP
RGD
PMID:24692845
RGD:13801194
NCBI chr 3:32,791,206...32,805,708
Ensembl chr 3:32,791,139...32,805,715
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
treatment
ISO IMP
RGD
PMID:23290949 PMID:24915518
RGD:10412734 , RGD:10412738
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
treatment
ISO
RGD
PMID:19616538
RGD:10413879
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Ngf
nerve growth factor
treatment
ISO
protein:increased expression:myocardium
RGD
PMID:20360245 PMID:20360245
RGD:405100231 , RGD:405100231
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Nlk
nemo like kinase
ISO
mRNA, protein:decreased expression:heart
RGD
PMID:26861724
RGD:242905213
NCBI chr11:78,457,994...78,588,848
Ensembl chr11:78,457,994...78,588,199
G
Nlrp3
NLR family, pyrin domain containing 3
ameliorates
ISO
RGD
PMID:33389498
RGD:242905187
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
G
Nono
non-POU-domain-containing, octamer binding protein
ameliorates
IDA
RGD
PMID:35247074
RGD:155882458
NCBI chr X:100,473,295...100,492,193
Ensembl chr X:100,472,924...100,492,197
G
Nos2
nitric oxide synthase 2, inducible
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:10090345 PMID:11489778 PMID:26192027
RGD:329970290
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
susceptibility treatment
ISO IEP
DNA:repeats:intron protein:decreased expression:aorta (rat) CTD Direct Evidence: marker/mechanism human gene in rat model DNA:duplication:intron:IVS4?-?+27 (human)
CTD RGD
PMID:10510054 PMID:16337503 PMID:10531147 PMID:29311930 PMID:28980197 PMID:22012955 PMID:17637430 PMID:12362496 PMID:11903359 More...
RGD:5128481 , RGD:13503346 , RGD:13450930 , RGD:7771563 , RGD:7771561 , RGD:1580283 , RGD:1580284
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Npm1
nucleophosmin 1
IEP
protein:increased expression:cardiomyocyte:
RGD
PMID:21444791
RGD:11535018
NCBI chr11:33,102,498...33,114,143
Ensembl chr11:33,102,287...33,113,206
G
Nppa
natriuretic peptide precursor type A
ISO
DNA:snp:cds:c.2238T>C (human) CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:9527094 PMID:11743230 PMID:12514664 PMID:16087130
RGD:1579982 , RGD:1580000
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
G
Nppb
natriuretic peptide type B
ISO
RGD
PMID:19858735 PMID:17639095 PMID:17256064
RGD:2324680 , RGD:7247724 , RGD:1642266
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
G
Npr1
natriuretic peptide receptor 1
susceptibility
ISO
DNA:missense mutation:cds:p.M341I (human)
RGD
PMID:14646971
RGD:1580174
NCBI chr 3:90,357,898...90,373,235
Ensembl chr 3:90,357,898...90,373,173
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
susceptibility
ISO
DNA:SNPs, haplotype:promoter:c.-115G>A, c.-840C>A (rs12221497, rs61896015) (human)
RGD
PMID:21903943
RGD:401842365
NCBI chr 2:91,014,406...91,033,189
Ensembl chr 2:91,014,406...91,033,179
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16413583 PMID:17587755
NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
G
Nrg1
neuregulin 1
treatment
ISO
RGD
PMID:24200746 PMID:26892146 PMID:27993643
RGD:10449026 , RGD:11522702 , RGD:405145704
NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825 Ensembl chr 8:32,304,579...33,374,825
G
Nrip1
nuclear receptor interacting protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22503866
NCBI chr16:76,084,291...76,170,930
Ensembl chr16:76,084,288...76,170,715
G
Olr1
oxidized low density lipoprotein (lectin-like) receptor 1
susceptibility
ISO
DNA:missense mutation:cds:p.K167N (human) ClinVar Annotator: match by term: Myocardial infarction, susceptibility to CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD RGD
PMID:12646194 PMID:12810610 PMID:14684693 PMID:25741868 PMID:12646194
RGD:1580996
NCBI chr 6:129,456,113...129,484,312
Ensembl chr 6:129,462,207...129,484,128
G
Opa1
OPA1, mitochondrial dynamin like GTPase
treatment
ISO
RGD
PMID:20886221
RGD:12738232
NCBI chr16:29,398,099...29,481,924
Ensembl chr16:29,398,152...29,473,702
G
Oprd1
opioid receptor, delta 1
ISO
RGD
PMID:12798419 PMID:15076225
RGD:2316587 , RGD:9831425
NCBI chr 4:131,834,980...131,872,042
Ensembl chr 4:131,838,037...131,871,797
G
Oprk1
opioid receptor, kappa 1
ISO
RGD
PMID:15076225
RGD:9831425
NCBI chr 1:5,658,673...5,676,357
Ensembl chr 1:5,658,689...5,676,354
G
P2ry12
purinergic receptor P2Y, G-protein coupled 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19334620
NCBI chr 3:59,123,692...59,170,408
Ensembl chr 3:59,123,693...59,170,292
G
Pappa
pregnancy-associated plasma protein A
susceptibility
ISO
DNA:polymorphism:intron CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11586954 PMID:17700210
RGD:1642324
NCBI chr 4:65,041,993...65,276,776
Ensembl chr 4:65,042,411...65,275,746
G
Parp1
poly (ADP-ribose) polymerase family, member 1
IEP
protein:altered processing:left ventricle (mouse)
RGD
PMID:21282286
RGD:5684012
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pcsk2
proprotein convertase subtilisin/kexin type 2
ISO
DNA:SNP:intron: (rs6080699) (human)
RGD
PMID:20036365
RGD:6483554
NCBI chr 2:143,388,053...143,658,204
Ensembl chr 2:143,388,076...143,658,205
G
Pde3a
phosphodiesterase 3A, cGMP inhibited
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19027736
NCBI chr 6:141,194,995...141,452,588
Ensembl chr 6:141,194,995...141,453,174
G
Pde5a
phosphodiesterase 5A, cGMP-specific
ISO
RGD
PMID:17339532
RGD:2314468
NCBI chr 3:122,522,822...122,653,023
Ensembl chr 3:122,522,596...122,653,023
G
Pdgfd
platelet-derived growth factor, D polypeptide
ISO
mRNA,protein:altered expression:myocardium:
RGD
PMID:21767547
RGD:9854703
NCBI chr 9:6,168,377...6,534,284
Ensembl chr 9:6,168,584...6,378,850
G
Pebp1
phosphatidylethanolamine binding protein 1
ISO
protein:decreased expression:right heart ventricle, ventricular septum
RGD
PMID:17089028
RGD:2302667
NCBI chr 5:117,420,716...117,425,629
Ensembl chr 5:117,420,719...117,425,690
G
Pecam1
platelet/endothelial cell adhesion molecule 1
onset no_association
ISO
DNA:polymorphisms: :p.N563S, p.G670R (human) DNA:missense mutation:cds:p.R643G (human) DNA:missense mutations:cds:p.L125V, p.S563N (human)
RGD
PMID:11795274 PMID:15488875 PMID:15265022
RGD:2311656 , RGD:6771224 , RGD:1581009
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pgf
placental growth factor
IDA ISO
RGD
PMID:20649603 PMID:21329947 PMID:22114497
RGD:6483584 , RGD:6483777 , RGD:6483773
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Phactr1
phosphatase and actin regulator 1
susceptibility severity no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:intron: (rs9369640) (human) DNA:SNPs:multiple (human) DNA:SNP:intron:(rs12526453) (human) mRNA:increased expression:peripheral blood mononuclear cells (human) DNA:SNPs:intron 3: (rs9349379, rs2026458, rs2876300) (human) DNA:SNP:intron:g.13035530G>C (rs12526453) (human) mRNA, protein:decreased expression:heart left ventricle (rat)
CTD RGD
PMID:19198609 PMID:26098115 PMID:25738804 PMID:25838425 PMID:26086777 PMID:33460763 PMID:33460763 PMID:19198609 PMID:26098115 More...
RGD:11052994 , RGD:11052493 , RGD:11056926 , RGD:401900171 , RGD:401900171 , RGD:401851907 , RGD:11053274
NCBI chr13:42,833,909...43,292,002
Ensembl chr13:42,834,099...43,292,002
G
Phlda3
pleckstrin homology like domain, family A, member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34351043
NCBI chr 1:135,693,823...135,696,872
Ensembl chr 1:135,693,857...135,696,874
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
IMP
RGD
PMID:20056919
RGD:6482688
NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658
G
Pla2g7
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
ISO
protein:decreased expression:serum
RGD
PMID:19644070
RGD:6482786
NCBI chr17:43,879,009...43,923,093
Ensembl chr17:43,878,989...43,923,092
G
Plat
plasminogen activator, tissue
treatment
ISO
DNA:snp:enhancer:g.-7351C>T (human) CTD Direct Evidence: therapeutic
CTD RGD
PMID:1430592 PMID:1492007 PMID:1898952 PMID:1899364 PMID:1900011 PMID:2104561 PMID:2105625 PMID:2494454 PMID:2505604 PMID:2521976 PMID:3089627 PMID:3121335 PMID:7488445 PMID:7723950 PMID:7775709 PMID:7902905 PMID:8328192 PMID:8554022 PMID:8598594 PMID:9183334 PMID:10171637 PMID:10505926 PMID:10645301 PMID:10914357 PMID:11382373 PMID:11489769 PMID:12074692 PMID:12227717 PMID:12848087 PMID:15215796 PMID:15301905 PMID:18195371 PMID:19341228 PMID:20122609 PMID:11848437 PMID:7994806 More...
RGD:1580881 , RGD:11541077
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plau
plasminogen activator, urokinase
ISO
DNA:SNP:3' utr:c.*141C>T (rs4065) (human) CTD Direct Evidence: marker/mechanism|therapeutic mRNA, protein:increased expression:myocardium
CTD RGD
PMID:1908371 PMID:2174952 PMID:2382605 PMID:3068399 PMID:3984876 PMID:8416330 PMID:20518747 PMID:17653104 PMID:20952728 More...
RGD:6484126 , RGD:6484145 , RGD:6484133
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Plaur
plasminogen activator, urokinase receptor
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:12393744 PMID:20952728
RGD:1580897 , RGD:6484133
NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393
G
Plcb1
phospholipase C, beta 1
ISO
protein:increased expression:heart
RGD
PMID:9521338
RGD:2314514
NCBI chr 2:134,628,084...135,317,178
Ensembl chr 2:134,627,987...135,317,178
G
Plcb3
phospholipase C, beta 3
ISO
protein:increased expression:heart
RGD
PMID:9521338
RGD:2314514
NCBI chr19:6,931,081...6,951,738
Ensembl chr19:6,929,693...6,953,838
G
Pln
phospholamban
treatment
ISO
protein:decreased expression:heart left ventricle (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16026515 PMID:16162791 PMID:23781262 PMID:26067684
RGD:7327176 , RGD:11097969
NCBI chr10:53,213,782...53,222,095
Ensembl chr10:53,213,763...53,222,083
G
Pon1
paraoxonase 1
ISO
RGD
PMID:10978258 PMID:10610741
RGD:1580202 , RGD:1580198
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
G
Postn
periostin, osteoblast specific factor
ISO
protein:increased expression:heart:
RGD
PMID:24212842
RGD:10041024
NCBI chr 3:54,266,688...54,298,462
Ensembl chr 3:54,268,530...54,298,458
G
Ppara
peroxisome proliferator activated receptor alpha
ISO
DNA:SNP:intron:rs4253623, minor allele associated with increased risk (human)
RGD
PMID:18549840
RGD:5562819
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Ppargc1a
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha
ISO
protein:decreased expression:heart CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22503866 PMID:22503866 PMID:22087236
RGD:7242181 , RGD:6484266
NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068
G
Prkce
protein kinase C, epsilon
ISO IEP
CTD Direct Evidence: therapeutic RNA:decreased expression:myocardium:
CTD RGD
PMID:16782078 PMID:28887629
RGD:155882580
NCBI chr17:86,472,631...86,965,347
Ensembl chr17:86,475,213...86,965,347
G
Prkd1
protein kinase D1
treatment
ISO
RGD
PMID:26064267
RGD:289474908
NCBI chr12:50,388,009...50,696,075
Ensembl chr12:50,388,014...50,695,881
G
Proc
protein C
ISO
RGD
PMID:10936861
RGD:11100014
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Psma6
proteasome subunit alpha 6
susceptibility
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Myocardial infarction, susceptibility to
CTD ClinVar OMIM
PMID:16845397 PMID:19282875 PMID:25741868
NCBI chr12:55,431,007...55,465,244
Ensembl chr12:55,431,007...55,465,239
G
Ptgis
prostaglandin I2 (prostacyclin) synthase
susceptibility
ISO
DNA:SNP::1117C>A (human) DNA:silent mutation:exon 8:1117C>A (human) DNA:SNP:CDS: (rs5629) (human)
RGD
PMID:19040046 PMID:12040339 PMID:19327107 PMID:19046748
RGD:401901147 , RGD:401901268 , RGD:401901155 , RGD:2313891
NCBI chr 2:167,045,114...167,095,069
Ensembl chr 2:167,033,725...167,082,524
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISO
RGD
PMID:15138244
RGD:1581289
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptn
pleiotrophin
ISO
protein:increased expression:myocardium (rat)
RGD
PMID:17925408
RGD:10044023
NCBI chr 6:36,691,863...36,787,114
Ensembl chr 6:36,691,864...36,787,155
G
Rad50
RAD50 double strand break repair protein
treatment
ISO
RGD
PMID:15623426
RGD:9831390
NCBI chr11:53,540,346...53,598,146
Ensembl chr11:53,540,346...53,598,146
G
Ranbp1
RAN binding protein 1
ISO
protein:decreased expression:heart ventricle, cytoplasm (rat)
RGD
PMID:25341891
RGD:9835001
NCBI chr16:18,057,843...18,066,558
Ensembl chr16:18,057,648...18,066,596
G
Rbp4
retinol binding protein 4, plasma
ISO
protein:increased expression:blood serum (human)
RGD
PMID:25142320
RGD:329845867
NCBI chr19:38,105,068...38,113,769
Ensembl chr19:38,105,077...38,113,729
G
Reg1
regenerating islet-derived 1
ISO
mRNA:increased expression:heart left ventricle (rat)
RGD
PMID:15778284
RGD:9850130
NCBI chr 6:78,402,966...78,405,651
Ensembl chr 6:78,399,694...78,405,650
G
Ren1
renin 1 structural
susceptibility
ISO
associated with Hypertension; protein:increased activity:plasma (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:1668233 PMID:1759997
RGD:6892687
NCBI chr 1:133,278,412...133,288,058
Ensembl chr 1:133,278,248...133,288,063
G
Retn
resistin
ISO
protein:increased expression:plasma
RGD
PMID:18997620
RGD:7207152
NCBI chr 8:3,705,770...3,709,818
Ensembl chr 8:3,705,770...3,710,110
G
Rps6kb1
ribosomal protein S6 kinase, polypeptide 1
ISO
protein:increased threonine phosphorylation:heart left ventricle
RGD
PMID:16540832
RGD:1642998
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
G
Ryr1
ryanodine receptor 1, skeletal muscle
ISO
protein:hyperphosphorylation:extensor digitorum longus:
RGD
PMID:12824280
RGD:329813076
NCBI chr 7:28,702,765...28,824,599
Ensembl chr 7:28,702,769...28,824,604
G
S100b
S100 protein, beta polypeptide, neural
ISO
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:9788975 PMID:19910580
RGD:2325647
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
G
Sdc1
syndecan 1
ISO
mRNA:increased expression:myocardium
RGD
PMID:9237025
RGD:2311712
NCBI chr12:8,821,396...8,843,716
Ensembl chr12:8,821,323...8,843,715
G
Sdc4
syndecan 4
ISO
protein:increased expression:plasma
RGD
PMID:11372670
RGD:2312328
NCBI chr 2:164,266,167...164,285,512
Ensembl chr 2:164,266,167...164,285,807
G
Sell
selectin, lymphocyte
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10070497
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
G
Selp
selectin, platelet
susceptibility
ISO
associated with Hypertension;protein:increased expression:plasma protein:increased expression:serum DNA:polymorphisms, haplotypes:cds:p.S290N, p.N562D, p.T715P (human)
RGD
PMID:17391113 PMID:21162967 PMID:21567088 PMID:12165563
RGD:2312304 , RGD:6219003 , RGD:6218991 , RGD:1580075
NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
susceptibility
ISO
DNA:deletion:promoter:g.-676_-674delG (human)
RGD
PMID:12477941 PMID:16053971
RGD:1626626 , RGD:8547882
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Sfrp2
secreted frizzled-related protein 2
ISO IMP
RGD
PMID:19109969 PMID:19079247
RGD:4107088 , RGD:155883169
NCBI chr 3:83,673,628...83,681,621
Ensembl chr 3:83,673,628...83,681,623
G
Sh2b3
SH2B adaptor protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198610
NCBI chr 5:121,953,544...121,975,706
Ensembl chr 5:121,953,551...121,975,709
G
Shh
sonic hedgehog
treatment
ISO
RGD
PMID:20052412
RGD:12879408
NCBI chr 5:28,661,838...28,672,099
Ensembl chr 5:28,661,813...28,672,254
G
Sirt1
sirtuin 1
ISO
protein:altered localization:nucleus
RGD
PMID:20089851
RGD:2316169
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Sirt3
sirtuin 3
treatment
ISO
RGD
PMID:24471974
RGD:9586050
NCBI chr 7:140,443,576...140,462,222
Ensembl chr 7:140,443,579...140,462,222
G
Slc27a1
solute carrier family 27 (fatty acid transporter), member 1
ISO
protein:decreased expression:heart
RGD
PMID:17034771
RGD:1642800
NCBI chr 8:72,021,372...72,039,951
Ensembl chr 8:72,021,526...72,039,946
G
Slc27a6
solute carrier family 27 (fatty acid transporter), member 6
ISO
protein:decreased expression:heart
RGD
PMID:17034771
RGD:1642800
NCBI chr18:58,689,312...58,745,941
Ensembl chr18:58,689,329...58,745,845
G
Slpi
secretory leukocyte peptidase inhibitor
treatment
ISO
RGD
PMID:23361363
RGD:9999400
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
G
Smad2
SMAD family member 2
treatment ameliorates
ISO IEP
RGD
PMID:11087260 PMID:33409963
RGD:12903276 , RGD:401794430
NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034
G
Smad3
SMAD family member 3
ameliorates
IEP
RGD
PMID:33409963
RGD:401794430
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
G
Smad4
SMAD family member 4
treatment
ISO
RGD
PMID:11087260
RGD:12903276
NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851
G
Socs1
suppressor of cytokine signaling 1
ISO
protein:increased expression:heart
RGD
PMID:16377761
RGD:2298918
NCBI chr16:10,601,672...10,603,400
Ensembl chr16:10,600,104...10,603,400
G
Sod1
superoxide dismutase 1, soluble
treatment
IDA ISO
CTD Direct Evidence: therapeutic human gene in a rat model
CTD RGD
PMID:21600015 PMID:11864929 PMID:22006090
RGD:1581222 , RGD:8655953
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:12160945 PMID:14575298 PMID:9250167
RGD:1581148 , RGD:1580839
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Sod3
superoxide dismutase 3, extracellular
ISO
RGD
PMID:14592844
RGD:1580841
NCBI chr 5:52,521,146...52,527,080
Ensembl chr 5:52,521,133...52,528,760
G
Sparc
secreted acidic cysteine rich glycoprotein
ISO
mRNA:increased expression:heart
RGD
PMID:12826287
RGD:2300056
NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
G
Spp1
secreted phosphoprotein 1
ISO IDA
RGD
PMID:12939547 PMID:14500723
RGD:1581386 , RGD:1581325
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
G
Srsf1
serine and arginine-rich splicing factor 1
treatment
ISO
protein:increased phosphorylation:heart left ventricle(rat)
RGD
PMID:26067684
RGD:11097969
NCBI chr11:87,937,325...87,944,583
Ensembl chr11:87,938,199...87,944,581
G
Tbx3
T-box 3
ISO
RGD
PMID:19341743
RGD:5132891
NCBI chr 5:119,808,600...119,822,789
Ensembl chr 5:119,808,734...119,822,789
G
Tbx5
T-box 5
treatment
ISO
RGD
PMID:23948075
RGD:7327215
NCBI chr 5:119,934,581...120,023,285
Ensembl chr 5:119,970,733...120,023,284
G
Tek
TEK receptor tyrosine kinase
ISO
protein:increased expression:ventricle myocardium
RGD
PMID:16714360
RGD:1601493
NCBI chr 4:94,627,322...94,763,213
Ensembl chr 4:94,627,526...94,763,213
G
Tfpi
tissue factor pathway inhibitor
treatment
ISO
mRNA,protein:increased expression:heart:
RGD
PMID:15630488 PMID:21229253 PMID:14656922
RGD:11060131 , RGD:11062083 , RGD:11060139
NCBI chr 2:84,263,199...84,307,119
Ensembl chr 2:84,263,199...84,307,119
G
Tgfb1
transforming growth factor, beta 1
susceptibility
ISO
associated with Coronary Disease;DNA:polymorphism:promoter:-509C>T (human) CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:heart:
CTD RGD
PMID:16310260 PMID:16543493 PMID:27121011 PMID:15118671
RGD:1601560 , RGD:11073666 , RGD:1331525
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfb2
transforming growth factor, beta 2
ISO
RGD
PMID:14575314
RGD:2302107
NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186
G
Tgfbr1
transforming growth factor, beta receptor I
ISO
RGD
PMID:10198196
RGD:1601617
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
G
Tgfbr2
transforming growth factor, beta receptor II
ISO
RGD
PMID:10198196
RGD:1601617
NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428
G
Th
tyrosine hydroxylase
no_association
ISO
DNA:polymorphism:intron:g.1170_1173dupTCAT (human)
RGD
PMID:16139102
RGD:1580048
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
G
Thbd
thrombomodulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9843165 PMID:10627464
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Thbs1
thrombospondin 1
ISO
mRNA, protein:increased expression:myocardium
RGD
PMID:16179730
RGD:2317960
NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
G
Timp2
tissue inhibitor of metalloproteinase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
G
Tlr4
toll-like receptor 4
ISO
DNA:SNP:intron:rs1927911, minor allele associated with decreased risk (human)
RGD
PMID:15864121 PMID:18549840
RGD:1580734 , RGD:5562819
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tm6sf2
transmembrane 6 superfamily member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24633158
NCBI chr 8:70,525,574...70,532,716
Ensembl chr 8:70,525,574...70,532,716
G
Tnc
tenascin C
ISO
protein:increased expression:heart, fibroblast
RGD
PMID:11454990
RGD:4889618
NCBI chr 4:63,878,022...63,965,554
Ensembl chr 4:63,878,022...63,965,252
G
Tnf
tumor necrosis factor
ISO
mRNA, protein:increased expression:left ventricle myocardium, plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15883752 PMID:16310260 PMID:21362018
RGD:5130892
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfrsf11b
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin)
ISO
RGD
PMID:15926884
RGD:1620893
NCBI chr15:54,114,014...54,141,700
Ensembl chr15:54,114,015...54,141,880
G
Tnfrsf12a
tumor necrosis factor receptor superfamily, member 12a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20082609
NCBI chr17:23,894,419...23,896,423
Ensembl chr17:23,894,419...23,896,442
G
Tnfrsf14
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)
ISO
protein:increased expression:heart, cardiomyocyte, endothelial cell (rat)
RGD
PMID:18353719
RGD:2317281
NCBI chr 4:155,002,944...155,013,077
Ensembl chr 4:155,006,390...155,013,020
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
ISO
mRNA, protein:increased expression:left ventricle myocardium (rat)
RGD
PMID:15117889 PMID:20651834 PMID:21362018
RGD:1624194 , RGD:5130975 , RGD:5130892
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tnfrsf1b
tumor necrosis factor receptor superfamily, member 1b
ISO
mRNA, protein:decreased expression:left ventricle myocardium (rat)
RGD
PMID:21362018
RGD:5130892
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
G
Tnfsf11
tumor necrosis factor (ligand) superfamily, member 11
ISO
protein:increased expression:serum
RGD
PMID:18298349
RGD:2302363
NCBI chr14:78,514,886...78,545,483
Ensembl chr14:78,514,885...78,545,483
G
Tnfsf4
tumor necrosis factor (ligand) superfamily, member 4
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
CTD OMIM RGD
PMID:15750594
RGD:1580396
NCBI chr 1:161,223,009...161,245,777
Ensembl chr 1:161,222,980...161,245,981
G
Tnni3
troponin I, cardiac 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12359538
NCBI chr 7:4,521,304...4,526,228
Ensembl chr 7:4,521,304...4,527,228
G
Tnnt2
troponin T2, cardiac
ISO
RGD
PMID:15226628
RGD:1580441
NCBI chr 1:135,763,933...135,780,006
Ensembl chr 1:135,764,092...135,779,998
G
Trem1
triggering receptor expressed on myeloid cells 1
ameliorates disease_progression
IMP ISO
RGD
PMID:25840803 PMID:25840803 PMID:25840803
RGD:127284842 , RGD:127284842 , RGD:127284842
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Trp53
transformation related protein 53
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24358288
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trpv1
transient receptor potential cation channel, subfamily V, member 1
ISO
RGD
PMID:27671317
RGD:13792689
NCBI chr11:73,124,975...73,152,148
Ensembl chr11:73,125,118...73,152,068
G
Ttn
titin
ISO
RGD
PMID:12221049
RGD:1580780
NCBI chr 2:76,534,324...76,812,901
Ensembl chr 2:76,534,324...76,812,891
G
Txn1
thioredoxin 1
ISO
RGD
PMID:14677813
RGD:1580785
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
G
Txnrd1
thioredoxin reductase 1
ISO
mRNA:decreased expression:heart left ventricle (rat)
RGD
PMID:18515646
RGD:5134341
NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546
G
Ubd
ubiquitin D
ISO
mRNA, protein; increased expression; myocardium (rat)
RGD
PMID:29438664
RGD:126925221
NCBI chr17:37,504,783...37,506,992
Ensembl chr17:37,504,783...37,506,986
G
Uts2
urotensin 2
ISO
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
RGD
PMID:15549273
RGD:2306846
NCBI chr 4:151,081,554...151,086,267
Ensembl chr 4:151,081,554...151,086,267
G
Uts2r
urotensin 2 receptor
ISO
associated with Heart Failure, Congestive;mRNA:increased expression:heart ventricle
RGD
PMID:15549273
RGD:2306846
NCBI chr11:121,051,097...121,052,799
Ensembl chr11:121,051,097...121,052,799
G
Vcan
versican
ISO
RGD
PMID:16311904
RGD:1598497
NCBI chr13:89,803,429...89,891,146
Ensembl chr13:89,803,431...89,890,628
G
Vdac1
voltage-dependent anion channel 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25488258
NCBI chr11:52,251,905...52,280,224
Ensembl chr11:52,251,687...52,280,224
G
Vdac2
voltage-dependent anion channel 2
treatment
ISO
RGD
PMID:20601275
RGD:10003049
NCBI chr14:21,881,629...21,895,947
Ensembl chr14:21,875,306...21,895,947
G
Vegfa
vascular endothelial growth factor A
treatment
ISO
protein:increased expression:serum,platelet:
RGD
PMID:10652191 PMID:25936512
RGD:7483604 , RGD:126925214
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vegfb
vascular endothelial growth factor B
ISO
RGD
PMID:17975666
RGD:2314324
NCBI chr19:6,959,840...6,965,019
Ensembl chr19:6,959,841...6,965,019
G
Vwf
Von Willebrand factor
ISO
protein:increased expression:heart:
RGD
PMID:19435557
RGD:11080745
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Wdr12
WD repeat domain 12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19198609 PMID:25915632
NCBI chr 1:60,110,520...60,137,659
Ensembl chr 1:60,108,944...60,137,804
G
Wrn
Werner syndrome RecQ like helicase
ISO
RGD
PMID:9021029
RGD:1580821
NCBI chr 8:33,724,400...33,875,591
Ensembl chr 8:33,724,412...33,875,555
G
Xrcc3
X-ray repair complementing defective repair in Chinese hamster cells 3
susceptibility
ISO
DNA:polymorphism:: (human)
RGD
PMID:18712175
RGD:401827276
NCBI chr12:111,769,626...111,780,326
Ensembl chr12:111,769,626...111,780,307
G
Ybx1
Y box protein 1
ISO
RGD
PMID:16002047
RGD:1580630
NCBI chr 4:119,134,524...119,153,462
Ensembl chr 4:119,135,178...119,151,801
G
Zeb2
zinc finger E-box binding homeobox 2
ISO
protein:increased expression:heart (rat)
RGD
PMID:24155330
RGD:155882536
NCBI chr 2:44,873,523...45,007,378
Ensembl chr 2:44,873,644...45,007,407
G
Arhgap17
Rho GTPase activating protein 17
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 7:122,878,372...122,969,171
Ensembl chr 7:122,878,441...122,969,138
G
Bax
BCL2-associated X protein
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
C3
complement component 3
ISO
RGD
PMID:26476955
RGD:11552746
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Cacng4
calcium channel, voltage-dependent, gamma subunit 4
ISO
mRNA:decreased expression:blood:
RGD
PMID:27746059
RGD:13524557
NCBI chr11:107,623,183...107,685,532
Ensembl chr11:107,623,183...107,685,383
G
Casp3
caspase 3
treatment
ISO
RGD
PMID:26550220
RGD:13782284
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp7
caspase 7
treatment
ISO
RGD
PMID:26550220
RGD:13782284
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Ccn1
cellular communication network factor 1
ameliorates
IEP
RGD
PMID:30371213
RGD:329845516
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
G
Dsc2
desmocollin 2
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr18:20,163,690...20,192,611
Ensembl chr18:20,163,690...20,192,611
G
Fos
FBJ osteosarcoma oncogene
treatment
ISO
RGD
PMID:23054911
RGD:405650598
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Fto
FTO alpha-ketoglutarate dependent dioxygenase
ISO
mRNA:increased expression:blood
RGD
PMID:35693610
RGD:329901852
NCBI chr 8:92,039,995...92,395,061
Ensembl chr 8:92,040,153...92,395,067
G
Gata5
GATA binding protein 5
susceptibility
ISO
DNA:SNPs:promoter:rs80197101, rs77067995 (human)
RGD
PMID:33684162
RGD:155260335
NCBI chr 2:179,966,881...179,977,296
Ensembl chr 2:179,966,926...179,976,492
G
Gp6
glycoprotein 6 (platelet)
ameliorates sexual_dimorphism
ISO
DNA:missense mutation:CDS:p.S219P (rs1613662) (human) DNA:missense mutation:intron 1, intron 5: (rs1671207, rs11084382) (human)
RGD
PMID:20227257 PMID:20227257
RGD:401794138 , RGD:401794138
NCBI chr 7:4,365,852...4,400,849
Ensembl chr 7:4,366,964...4,400,743
G
Gpx3
glutathione peroxidase 3
ISO
protein:increased expression:plasma
RGD
PMID:28374671
RGD:401827832
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Gsk3b
glycogen synthase kinase 3 beta
treatment ameliorates
ISO
RGD
PMID:26591365 PMID:32068187
RGD:13792778 , RGD:267358468
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
H19
H19, imprinted maternally expressed transcript
ameliorates
ISO
RGD
PMID:31755219
RGD:213230161
NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,131,917
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
ISO
ClinVar Annotator: match by term: Acute myocardial infarction
ClinVar
PMID:20946881 PMID:21250968 PMID:21596855 PMID:21997850 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22616558 PMID:22898539 PMID:23949315 PMID:24606448 PMID:25157968 PMID:26619011 More...
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Ifng
interferon gamma
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Ikbkg
inhibitor of kappaB kinase gamma
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr X:73,436,883...73,498,013
Ensembl chr X:73,436,896...73,497,460
G
Il10
interleukin 10
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il17a
interleukin 17A
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il1b
interleukin 1 beta
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rl1
interleukin 1 receptor-like 1
ISO
RGD
PMID:24837094
RGD:40813741
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il33
interleukin 33
ISO
RGD
PMID:24837094
RGD:40813741
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Il4
interleukin 4
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il6
interleukin 6
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Itgam
integrin alpha M
treatment
ISO
RGD
PMID:21238619
RGD:329901664
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
G
Kif6
kinesin family member 6
ISO
DNA:SNP: :p.W719R (rs20455) (human)
RGD
PMID:20044086
RGD:243048455
NCBI chr17:49,922,121...50,216,875
Ensembl chr17:49,922,164...50,216,875
G
Malat1
metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA)
ameliorates
IMP
RGD
PMID:29990866
RGD:155882565
NCBI chr19:5,845,718...5,852,700
Ensembl chr19:5,845,717...5,852,706
G
Mir126a
microRNA 126a
disease_progression
ISO
RGD
PMID:36523365 PMID:32595526
RGD:401851047 , RGD:401851053
NCBI chr 2:26,481,369...26,481,441
Ensembl chr 2:26,481,369...26,481,441
G
Mir146
microRNA 146
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
G
Mir155
microRNA 155
ISO
miRNA:decreased expression:peripheral blood mononuclear cell, plasma
RGD
PMID:31866771
RGD:21081515
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir17
microRNA 17
treatment
ISO
RGD
PMID:29536180
RGD:329403057
NCBI chr14:115,281,103...115,281,186
Ensembl chr14:115,281,103...115,281,186
G
Mir21a
microRNA 21a
ISO
miRNA:increased expression:peripheral blood mononuclear cell, plasma RNA:decreased expression:serum
RGD
PMID:31866771 PMID:32595526
RGD:21081515 , RGD:401851053
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
G
Mir223
microRNA 223
treatment
ISO
RGD
PMID:29689569
RGD:25823140
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mir320
microRNA 320
IMP
RGD
PMID:29990866
RGD:155882565
NCBI chr14:70,680,950...70,681,031
Ensembl chr14:70,680,950...70,681,031
G
mt-Co2
cytochrome c oxidase II, mitochondrial
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr MT:7,013...7,696
Ensembl chr MT:7,013...7,696
G
Ndufb5
NADH:ubiquinone oxidoreductase subunit B5
ameliorates
ISO
associated with obesity
RGD
PMID:35257523
RGD:401794445
NCBI chr 3:32,791,206...32,805,708
Ensembl chr 3:32,791,139...32,805,715
G
Pf4
platelet factor 4
treatment
ISO
RGD
PMID:29407168
RGD:329901925
NCBI chr 5:90,920,362...90,921,242
Ensembl chr 5:90,920,294...90,921,242
G
Plcg1
phospholipase C, gamma 1
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 2:160,573,230...160,617,680
Ensembl chr 2:160,573,220...160,617,680
G
Ppbp
pro-platelet basic protein
treatment
ISO
RGD
PMID:29407168
RGD:329901925
NCBI chr 5:90,916,377...90,917,922
Ensembl chr 5:90,916,377...90,917,922
G
Pten
phosphatase and tensin homolog
ameliorates
ISO IEP
mRNA:decreased expression:heart left ventricle (rat) RNA:increased expression:serum
RGD
PMID:26973267 PMID:32595526 PMID:29990866
RGD:11526378 , RGD:401851053 , RGD:155882565
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
G
Rhoa
ras homolog family member A
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Rit2
Ras-like without CAAX 2
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr18:31,107,367...31,450,181
Ensembl chr18:31,106,542...31,450,343
G
Sdhb
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
ameliorates
ISO
associated with obesity
RGD
PMID:35257523
RGD:401794445
NCBI chr 4:140,688,582...140,706,509
Ensembl chr 4:140,688,514...140,706,504
G
Serping1
serine (or cysteine) peptidase inhibitor, clade G, member 1
ISO
mRNA:increased expression:heart
RGD
PMID:26476955 PMID:26476955
RGD:11552746 , RGD:11552746
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
G
Tbx1
T-box 1
treatment
ISO
RGD
PMID:27422448
RGD:155882497
NCBI chr16:18,399,729...18,409,412
Ensembl chr16:18,399,729...18,409,421
G
Tnf
tumor necrosis factor
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Zeb1
zinc finger E-box binding homeobox 1
ameliorates
ISO
RGD
PMID:32068187
RGD:267358468
NCBI chr18:5,591,330...5,775,468
Ensembl chr18:5,591,860...5,775,467
G
Edn1
endothelin 1
ISO
protein:increased expression:aortic root, coronary sinus, plasma (human)
RGD
PMID:12581682
RGD:8661757
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
disease_progression
IEP IMP
protein:decreased expression, decreased activity:heart:
RGD
PMID:12615902 PMID:12615902
RGD:13208541 , RGD:13208541
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Epo
erythropoietin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19337937
NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504
G
Plat
plasminogen activator, tissue
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:1430592
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Sod2
superoxide dismutase 2, mitochondrial
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21062213
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Mef2a
myocyte enhancer factor 2A
ISO
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant, 1 | ClinVar Annotator: match by term: Coronary artery disease/myocardial infarction CTD Direct Evidence: marker/mechanism
OMIM ClinVar CTD
PMID:14645853 PMID:15496429 PMID:15841183 PMID:25741868
NCBI chr 7:66,880,911...67,026,435
Ensembl chr 7:66,880,911...67,022,606
G
Cad
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant 2
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 5:31,211,964...31,235,823
Ensembl chr 5:31,212,124...31,235,823
G
Lrp6
low density lipoprotein receptor-related protein 6
ISO
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Coronary artery disease, autosomal dominant 2
OMIM CTD ClinVar
PMID:17332414 PMID:23703864 PMID:25741868 PMID:28492532
NCBI chr 6:134,423,439...134,543,876
Ensembl chr 6:134,423,439...134,543,928
G
Atp2a2
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16317512
NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
G
Nos2
nitric oxide synthase 2, inducible
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11927517
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Pln
phospholamban
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16317512
NCBI chr10:53,213,782...53,222,095
Ensembl chr10:53,213,763...53,222,083
G
Tnf
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11927517
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Cdh5
cadherin 5
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr 8:104,828,247...104,871,136
Ensembl chr 8:104,828,257...104,871,143
G
Ctnnb1
catenin beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Jup
junction plakoglobin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16824628
NCBI chr11:100,259,682...100,288,639
Ensembl chr11:100,259,784...100,288,589
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
treatment
ISO
DNA:SNPs: :rs1045642,rs7779562(human)
RGD
PMID:25217066
RGD:14700903
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Atp5mc2
ATP synthase membrane subunit c locus 2
severity
ISO
RGD
PMID:27441480
RGD:14696800
NCBI chr15:102,571,303...102,579,482
Ensembl chr15:102,571,299...102,580,787
G
Ccn1
cellular communication network factor 1
sexual_dimorphism
ISO
protein:increased expression:blood serum (human)
RGD
PMID:34597881
RGD:329845519
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
G
Lgals3
lectin, galactose binding, soluble 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29769800
NCBI chr14:47,611,317...47,623,624
Ensembl chr14:47,605,208...47,623,617
G
Mir208a
microRNA 208a
severity
ISO
miRNA:increased expression:blood
RGD
PMID:32458401
RGD:213230165
NCBI chr14:55,186,517...55,186,599
Ensembl chr14:55,186,517...55,186,599
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all